loader image
Saturday, February 14, 2026
73 F
McAllen
- Advertisement -

DHR Health Institute for Research and Development Recognized as a “Top Performing Site” Once Again

Translate to Spanish or other 102 languages!

THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
- Advertisement -

EDINBURG, Texas – The DHR Health Institute for Research and Development is delighted to announce that it has once again been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This marks the third consecutive time the Institute has received this prestigious distinction.

This recognition highlights the ongoing excellence and impact of the Research Institute as it continues to advance cancer research and improve patient outcomes.

“We are deeply honored and this recognition would not be possible without the assistance of the DHR Health Oncology Institute and the leadership of Dr. Jose Cruz,” said Dr. Scott Lillibridge, executive vice president for the DHR Health Institute for Research and Development.

- Advertisement -

SWOG is a global cancer research community supported by the National Cancer Institute (NCI), and recognition as a “Top Performing Site” signifies exceptional performance in clinical trial enrollment, data quality, and patient care standards.

The DHR Health Institute for Research and Development remains committed to innovation and delivering high-quality research opportunities to all residents of the Rio Grande Valley. They are located at 5323 S. McColl Road in Edinburg. For more information about clinical trials in the areas of liver, obesity, cancer, neurology, oncology and urology, call the Institute at (956) 362-2390.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

South Central Texas McDonald’s Restaurants Raise Funds for RMHC Through Feb. 15

This Valentine’s Day weekend, local McDonald’s restaurants across South Central Texas are giving the community a meaningful way to “Share the Love.” through Sunday, February 15, customers are invited to stop by participating McDonald’s locations and donate $1, $3, or $5 to benefit local Ronald McDonald House Charities® (RMHC).

Implanted Devices Offer Insight Into How Parkinson’s Patients Move at Home

Mega Doctor News By University of California, San Francisco (UCSF) Newswise — Scientists have traditionally...

Breakthrough TTFields Technology Gets FDA Approval for Pancreatic Cancer Treatment

Mega Doctor News The U.S. Food and Drug Administration has approved a...

El Paso Researchers Advance New Treatments for Cancer and Heart Disease

Ramadevi Subramani Reddy, Ph.D., remembers the neem tree from her childhood in India — a plant her grandmother used to treat everything from fevers to infections.
- Advertisement -
×